We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about atrial fibrillation in patients with hypertrophic cardiomyopathy.
Questions:
- What is the incidence of atrial fibrillation (AF) in people with hypertrophic cardiomyopathy (HCM)? (0.13)
- What is known about the efficacy and safety of catheter ablation of AF in patients with HCM compared to those without HCM? (0.43)
- How can outcomes be improved in this patient population? (5.00)
Speaker disclosures: Professor David Keane has nothing to declare in relation to this video interview.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor David Keane as a highlight of the AF Symposium, January 2021.
